Corwin covers the Healthcare sector, focusing on stocks such as PTC Therapeutics, Zevra Therapeutics, and Poseida Therapeutics. According to TipRanks, Corwin has an average return of 4.1% and a 50.79% ...
Currently, the analyst consensus on PTC Therapeutics is a Hold with an average price target of $42.40, a -5.1% downside from current levels. In a report issued on November 7, RBC Capital also ...
PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...
Future of Healthcategory Eli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free November 13, 2024 ...
PTC Therapeutics (NASDAQ:PTCT) has received FDA approval for its gene replacement therapy Kebilidi for the treatment of ...
PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $106.7 million in its third quarter. The Warren, New Jersey-based company said it had a loss of $1.39 per share. The results surpassed ...
At the start of the year, the company said it expected to make as much as $1 billion in revenue ... 2024 Future of ...
Copyright © 2024 MarketWatch, Inc. All rights reserved.
When the Houston Rockets needed help with their worst uniforms, they turned to artist and costumer Eiko Ishioka.
Game Rant on MSN3d
Hideo Kojima Reveals Origin Of Death Stranding LogoTo honor the fifth anniversary of Death Stranding, creator Hideo Kojima reveals the surprising origin behind the game's ...
Here are some fun videos for you to watch created by graphic designer Kostya Petrenko. He has been creating retro 1980s-style logos for modern brands like Netflix, Spotify, Google, and OpenAI. Some of ...
The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback